person · Reporting owner

HILL BARBARA B

Disclosed activity across 4 companies

Tapewire entity: 40262
SEC CIK: 0001235676

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
ACCENDRA HEALTH INC/VA/OMI · Entity 6858	Director	June 28, 2019	July 02, 2019
INTEGRA LIFESCIENCES HOLDINGS CORPIART · Entity 2707	Director	May 07, 2026	May 11, 2026
OMEGA HEALTHCARE INVESTORS INCOHI · Entity 3362	Director	June 05, 2026	June 09, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

ACCENDRA HEALTH INC/VA/

Report date June 28, 2019 · Filed July 02, 2019

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Phantom StockSEC Table II · derivative / convertible security	Direct	21,718	Reported balance After 2019-06-28 transaction · row 1 Instrument identity requires review; Table II rows are not merged. 1 source row Row 1 · 2019-06-28 · Grant · Acquired 17 · Balance 21,718 F1: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). F2: Shares acquired through quarterly dividend reinvestment transaction.

Filing footnotes · ownership attribution and instrument terms

F1: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).

F2: Shares acquired through quarterly dividend reinvestment transaction.

INTEGRA LIFESCIENCES HOLDINGS CORP

Report date May 07, 2026 · Filed May 11, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	151,191	Ending reported balance After 2026-05-07 transaction · row 2 2 source rows · reconciled sequence Row 1 · 2026-05-07 · Grant · Acquired 6,638 · Balance 133,491 Row 2 · 2026-05-07 · Grant · Acquired 17,700 · Balance 151,191
Common StockSEC Table I · non-derivative	IndirectBy Trust	36,350	Reported balance Holding disclosure · report date 2026-05-07 · row 3 Holding and transaction disclosures are not merged. 1 source row Row 3 · Balance 36,350

OMEGA HEALTHCARE INVESTORS INC

Report date June 05, 2026 · Filed June 09, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Profits Interest UnitsSEC Table II · derivative / convertible security	Direct	0	Reported balance After 2026-06-05 transaction · row 1 Instrument identity requires review; Table II rows are not merged. 1 source row Row 1 · 2026-06-05 · Exercise / conversion · Disposed 7,079 · Balance 0 F1: Represents Profits Interest Units ("PIUs") in OHI Healthcare Properties Limited Partnership (the "Operating Partnership"), of which the Issuer is the general partner. Each PIU represents a contingent right to receive one unit of limited partnership interest (an "OP Unit") in the Operating Partnership upon vesting and the satisfaction of certain tax-driven economic requirements. F2: Each OP Unit is redeemable at the election of the holder for cash equal to the then fair market value of one share of Issuer common stock, or at the Issuer's election, one share of Issuer's common stock, subject to adjustment as set forth in the partnership agreement. OP Units do not expire. F3: 100% of the reporting person's PIUs granted on June 5, 2025 vested and converted into OP Units on June 5, 2026.
Profits Interest UnitsSEC Table II · derivative / convertible security	Direct	6,102	Reported balance After 2026-06-05 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2026-06-05 · Grant · Acquired 6,102 · Balance 6,102 F1: Represents Profits Interest Units ("PIUs") in OHI Healthcare Properties Limited Partnership (the "Operating Partnership"), of which the Issuer is the general partner. Each PIU represents a contingent right to receive one unit of limited partnership interest (an "OP Unit") in the Operating Partnership upon vesting and the satisfaction of certain tax-driven economic requirements. F2: Each OP Unit is redeemable at the election of the holder for cash equal to the then fair market value of one share of Issuer common stock, or at the Issuer's election, one share of Issuer's common stock, subject to adjustment as set forth in the partnership agreement. OP Units do not expire. F4: Represents the annual grant of stock the reporting person election to receive as Profits Interest Units. F5: 100% of the reporting person's PIUs granted on June 5, 2026 will vest on the date of the Company's 2027 Annual Meeting of Shareholders, subject to continued service.
OP UnitsSEC Table II · derivative / convertible security	Direct	49,073	Reported balance After 2026-06-05 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2026-06-05 · Exercise / conversion · Acquired 7,079 · Balance 49,073 F2: Each OP Unit is redeemable at the election of the holder for cash equal to the then fair market value of one share of Issuer common stock, or at the Issuer's election, one share of Issuer's common stock, subject to adjustment as set forth in the partnership agreement. OP Units do not expire.

Filing footnotes · ownership attribution and instrument terms

F1: Represents Profits Interest Units ("PIUs") in OHI Healthcare Properties Limited Partnership (the "Operating Partnership"), of which the Issuer is the general partner. Each PIU represents a contingent right to receive one unit of limited partnership interest (an "OP Unit") in the Operating Partnership upon vesting and the satisfaction of certain tax-driven economic requirements.

F2: Each OP Unit is redeemable at the election of the holder for cash equal to the then fair market value of one share of Issuer common stock, or at the Issuer's election, one share of Issuer's common stock, subject to adjustment as set forth in the partnership agreement. OP Units do not expire.

F3: 100% of the reporting person's PIUs granted on June 5, 2025 vested and converted into OP Units on June 5, 2026.

F4: Represents the annual grant of stock the reporting person election to receive as Profits Interest Units.

F5: 100% of the reporting person's PIUs granted on June 5, 2026 will vest on the date of the Company's 2027 Annual Meeting of Shareholders, subject to continued service.

Past disclosures · reporting ended (1)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

ST JUDE MEDICAL, LLC

Report date January 04, 2017 · Filed January 06, 2017

Section 16 reporting ended · disclosed 2017-01-06. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosure context
Common StockSEC Table I · non-derivative	Direct	Reported balance After 2017-01-04 transaction · row 1 1 source row Row 1 · 2017-01-04 · Disposition to issuer · Disposed 32,863 · Balance 0 F1: Pursuant to the terms of the Agreement and Plan of Merger, dated April 27, 2016, by and among Abbott Laboratories ("Abbott"), the Issuer, Vault Merger Sub, Inc. and Vault Merger Sub, LLC (the "Merger Agreement"), each share of Issuer Common Stock was cancelled in exchange for $46.75 in cash and 0.8708 of a share of Abbott Common Stock (the "Merger Consideration"), less any applicable withholding taxes, and provided that cash is payable in respect of any fractional shares of Abbott stock.
Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $36.45 · Expires 2017-05-08	Direct	Reported balance After 2017-01-04 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2017-01-04 · Disposition to issuer · Disposed 10,000 · Balance 0 F2: Pursuant to the Merger Agreement, each option that was fully vested and exercisable immediately prior to the mergers contemplated by the Merger Agreement (the "Mergers"), was deemed exercised pursuant to a cashless exercise and settled by issuance of a number of shares of Issuer Common Stock ("Net Exercise Shares") equal to the excess (rounded down to the nearest whole share, but with any partial shares otherwise issuable settled in cash) of (i) the number of shares of Issuer Common Stock subject to such option immediately prior to the Mergers over (ii) the number of whole and partial (computed to the nearest four decimal places) shares of Issuer Common Stock with a Fair Market Value equal to the aggregate exercise price of such option. Each Net Exercise Share was then canceled and converted into the right to receive the Merger Consideration, less any applicable withholding taxes.
Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $36.45 · Expires 2017-05-08	Direct	Reported balance After 2017-01-04 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2017-01-04 · Disposition to issuer · Disposed 2,250 · Balance 0 F2: Pursuant to the Merger Agreement, each option that was fully vested and exercisable immediately prior to the mergers contemplated by the Merger Agreement (the "Mergers"), was deemed exercised pursuant to a cashless exercise and settled by issuance of a number of shares of Issuer Common Stock ("Net Exercise Shares") equal to the excess (rounded down to the nearest whole share, but with any partial shares otherwise issuable settled in cash) of (i) the number of shares of Issuer Common Stock subject to such option immediately prior to the Mergers over (ii) the number of whole and partial (computed to the nearest four decimal places) shares of Issuer Common Stock with a Fair Market Value equal to the aggregate exercise price of such option. Each Net Exercise Share was then canceled and converted into the right to receive the Merger Consideration, less any applicable withholding taxes.
Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $37.15 · Expires 2018-05-07	Direct	Reported balance After 2017-01-04 transaction · row 4 Instrument identity requires review; Table II rows are not merged. 1 source row Row 4 · 2017-01-04 · Disposition to issuer · Disposed 10,000 · Balance 0 F2: Pursuant to the Merger Agreement, each option that was fully vested and exercisable immediately prior to the mergers contemplated by the Merger Agreement (the "Mergers"), was deemed exercised pursuant to a cashless exercise and settled by issuance of a number of shares of Issuer Common Stock ("Net Exercise Shares") equal to the excess (rounded down to the nearest whole share, but with any partial shares otherwise issuable settled in cash) of (i) the number of shares of Issuer Common Stock subject to such option immediately prior to the Mergers over (ii) the number of whole and partial (computed to the nearest four decimal places) shares of Issuer Common Stock with a Fair Market Value equal to the aggregate exercise price of such option. Each Net Exercise Share was then canceled and converted into the right to receive the Merger Consideration, less any applicable withholding taxes.
Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $37.15 · Expires 2018-05-07	Direct	Reported balance After 2017-01-04 transaction · row 5 Instrument identity requires review; Table II rows are not merged. 1 source row Row 5 · 2017-01-04 · Disposition to issuer · Disposed 600 · Balance 0 F2: Pursuant to the Merger Agreement, each option that was fully vested and exercisable immediately prior to the mergers contemplated by the Merger Agreement (the "Mergers"), was deemed exercised pursuant to a cashless exercise and settled by issuance of a number of shares of Issuer Common Stock ("Net Exercise Shares") equal to the excess (rounded down to the nearest whole share, but with any partial shares otherwise issuable settled in cash) of (i) the number of shares of Issuer Common Stock subject to such option immediately prior to the Mergers over (ii) the number of whole and partial (computed to the nearest four decimal places) shares of Issuer Common Stock with a Fair Market Value equal to the aggregate exercise price of such option. Each Net Exercise Share was then canceled and converted into the right to receive the Merger Consideration, less any applicable withholding taxes.
Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $52.17 · Expires 2019-05-12	Direct	Reported balance After 2017-01-04 transaction · row 6 Instrument identity requires review; Table II rows are not merged. 1 source row Row 6 · 2017-01-04 · Disposition to issuer · Disposed 9,700 · Balance 0 F2: Pursuant to the Merger Agreement, each option that was fully vested and exercisable immediately prior to the mergers contemplated by the Merger Agreement (the "Mergers"), was deemed exercised pursuant to a cashless exercise and settled by issuance of a number of shares of Issuer Common Stock ("Net Exercise Shares") equal to the excess (rounded down to the nearest whole share, but with any partial shares otherwise issuable settled in cash) of (i) the number of shares of Issuer Common Stock subject to such option immediately prior to the Mergers over (ii) the number of whole and partial (computed to the nearest four decimal places) shares of Issuer Common Stock with a Fair Market Value equal to the aggregate exercise price of such option. Each Net Exercise Share was then canceled and converted into the right to receive the Merger Consideration, less any applicable withholding taxes.
Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $38.51 · Expires 2020-05-03	Direct	Reported balance After 2017-01-04 transaction · row 7 Instrument identity requires review; Table II rows are not merged. 1 source row Row 7 · 2017-01-04 · Disposition to issuer · Disposed 10,000 · Balance 0 F2: Pursuant to the Merger Agreement, each option that was fully vested and exercisable immediately prior to the mergers contemplated by the Merger Agreement (the "Mergers"), was deemed exercised pursuant to a cashless exercise and settled by issuance of a number of shares of Issuer Common Stock ("Net Exercise Shares") equal to the excess (rounded down to the nearest whole share, but with any partial shares otherwise issuable settled in cash) of (i) the number of shares of Issuer Common Stock subject to such option immediately prior to the Mergers over (ii) the number of whole and partial (computed to the nearest four decimal places) shares of Issuer Common Stock with a Fair Market Value equal to the aggregate exercise price of such option. Each Net Exercise Share was then canceled and converted into the right to receive the Merger Consideration, less any applicable withholding taxes.
Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $38.51 · Expires 2020-05-03	Direct	Reported balance After 2017-01-04 transaction · row 8 Instrument identity requires review; Table II rows are not merged. 1 source row Row 8 · 2017-01-04 · Disposition to issuer · Disposed 5,400 · Balance 0 F2: Pursuant to the Merger Agreement, each option that was fully vested and exercisable immediately prior to the mergers contemplated by the Merger Agreement (the "Mergers"), was deemed exercised pursuant to a cashless exercise and settled by issuance of a number of shares of Issuer Common Stock ("Net Exercise Shares") equal to the excess (rounded down to the nearest whole share, but with any partial shares otherwise issuable settled in cash) of (i) the number of shares of Issuer Common Stock subject to such option immediately prior to the Mergers over (ii) the number of whole and partial (computed to the nearest four decimal places) shares of Issuer Common Stock with a Fair Market Value equal to the aggregate exercise price of such option. Each Net Exercise Share was then canceled and converted into the right to receive the Merger Consideration, less any applicable withholding taxes.

Filing footnotes · ownership attribution and instrument terms

F1: Pursuant to the terms of the Agreement and Plan of Merger, dated April 27, 2016, by and among Abbott Laboratories ("Abbott"), the Issuer, Vault Merger Sub, Inc. and Vault Merger Sub, LLC (the "Merger Agreement"), each share of Issuer Common Stock was cancelled in exchange for $46.75 in cash and 0.8708 of a share of Abbott Common Stock (the "Merger Consideration"), less any applicable withholding taxes, and provided that cash is payable in respect of any fractional shares of Abbott stock.

F2: Pursuant to the Merger Agreement, each option that was fully vested and exercisable immediately prior to the mergers contemplated by the Merger Agreement (the "Mergers"), was deemed exercised pursuant to a cashless exercise and settled by issuance of a number of shares of Issuer Common Stock ("Net Exercise Shares") equal to the excess (rounded down to the nearest whole share, but with any partial shares otherwise issuable settled in cash) of (i) the number of shares of Issuer Common Stock subject to such option immediately prior to the Mergers over (ii) the number of whole and partial (computed to the nearest four decimal places) shares of Issuer Common Stock with a Fair Market Value equal to the aggregate exercise price of such option. Each Net Exercise Share was then canceled and converted into the right to receive the Merger Consideration, less any applicable withholding taxes.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
June 05, 2026 Filed Jun 9, 2026 20:15 UTC	OMEGA HEALTHCARE INVESTORS INC OHI · Entity 3362	GrantProfits Interest Units · Derivative	6,102	$0.00	$0.00	Disclosure SEC source: 0001235676-26-000003 · form4-06092026_040628.xml · derivative · entry 3 HILL BARBARA B · CIK 0001235676 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,102 Underlying: OP Units · 6,102 shares Expires not disclosed F1 · derivative.exercise_price: Represents Profits Interest Units ("PIUs") in OHI Healthcare Properties Limited Partnership (the "Operating Partnership"), of which the Issuer is the general partner. Each PIU represents a contingent right to receive one unit of limited partnership interest (an "OP Unit") in the Operating Partnership upon vesting and the satisfaction of certain tax-driven economic requirements. F2 · derivative.exercise_price: Each OP Unit is redeemable at the election of the holder for cash equal to the then fair market value of one share of Issuer common stock, or at the Issuer's election, one share of Issuer's common stock, subject to adjustment as set forth in the partnership agreement. OP Units do not expire. F4 · shares: Represents the annual grant of stock the reporting person election to receive as Profits Interest Units. F5 · derivative.exercise_date: 100% of the reporting person's PIUs granted on June 5, 2026 will vest on the date of the Company's 2027 Annual Meeting of Shareholders, subject to continued service. F5 · derivative.expiration_date: 100% of the reporting person's PIUs granted on June 5, 2026 will vest on the date of the Company's 2027 Annual Meeting of Shareholders, subject to continued service. Read SEC document
June 05, 2026 Filed Jun 9, 2026 20:15 UTC	OMEGA HEALTHCARE INVESTORS INC OHI · Entity 3362	Exercise / conversionOP Units · Derivative	7,079	$0.00	$0.00	Disclosure SEC source: 0001235676-26-000003 · form4-06092026_040628.xml · derivative · entry 2 HILL BARBARA B · CIK 0001235676 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,073 Underlying: Common Stock · 7,079 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each OP Unit is redeemable at the election of the holder for cash equal to the then fair market value of one share of Issuer common stock, or at the Issuer's election, one share of Issuer's common stock, subject to adjustment as set forth in the partnership agreement. OP Units do not expire. F2 · derivative.exercise_date: Each OP Unit is redeemable at the election of the holder for cash equal to the then fair market value of one share of Issuer common stock, or at the Issuer's election, one share of Issuer's common stock, subject to adjustment as set forth in the partnership agreement. OP Units do not expire. F2 · derivative.expiration_date: Each OP Unit is redeemable at the election of the holder for cash equal to the then fair market value of one share of Issuer common stock, or at the Issuer's election, one share of Issuer's common stock, subject to adjustment as set forth in the partnership agreement. OP Units do not expire. Read SEC document
June 05, 2026 Filed Jun 9, 2026 20:15 UTC	OMEGA HEALTHCARE INVESTORS INC OHI · Entity 3362	Exercise / conversionProfits Interest Units · Derivative	7,079	$0.00	$0.00	Disclosure SEC source: 0001235676-26-000003 · form4-06092026_040628.xml · derivative · entry 1 HILL BARBARA B · CIK 0001235676 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: OP Units · 7,079 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Represents Profits Interest Units ("PIUs") in OHI Healthcare Properties Limited Partnership (the "Operating Partnership"), of which the Issuer is the general partner. Each PIU represents a contingent right to receive one unit of limited partnership interest (an "OP Unit") in the Operating Partnership upon vesting and the satisfaction of certain tax-driven economic requirements. F2 · derivative.exercise_price: Each OP Unit is redeemable at the election of the holder for cash equal to the then fair market value of one share of Issuer common stock, or at the Issuer's election, one share of Issuer's common stock, subject to adjustment as set forth in the partnership agreement. OP Units do not expire. F3 · derivative.exercise_date: 100% of the reporting person's PIUs granted on June 5, 2025 vested and converted into OP Units on June 5, 2026. F3 · derivative.expiration_date: 100% of the reporting person's PIUs granted on June 5, 2025 vested and converted into OP Units on June 5, 2026. Read SEC document
May 07, 2026 Filed May 11, 2026 20:41 UTC	INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707	GrantCommon Stock	17,700	$0.00	$0.00	Disclosure SEC source: 0001235676-26-000001 · wk-form4_1778532093.xml · nonDerivative · entry 2 HILL BARBARA B · CIK 0001235676 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 151,191 Read SEC document
May 07, 2026 Filed May 11, 2026 20:41 UTC	INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707	GrantCommon Stock	6,638	$0.00	$0.00	Disclosure SEC source: 0001235676-26-000001 · wk-form4_1778532093.xml · nonDerivative · entry 1 HILL BARBARA B · CIK 0001235676 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 133,491 Read SEC document
June 06, 2025 Filed Jun 10, 2025 20:05 UTC	OMEGA HEALTHCARE INVESTORS INC OHI · Entity 3362	Exercise / conversionProfits Interest Units · Derivative	7,472	$0.00	$0.00	Disclosure SEC source: 0001415889-25-016459 · form4-06102025_040609.xml · derivative · entry 1 HILL BARBARA B · CIK 0001235676 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: OP Units · 7,472 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Represents Profits Interest Units ("PIUs") in OHI Healthcare Properties Limited Partnership (the "Operating Partnership"), of which the Issuer is the general partner. Each PIU represents a contingent right to receive one unit of limited partnership interest (an "OP Unit") in the Operating Partnership upon vesting and the satisfaction of certain tax-driven economic requirements. F2 · derivative.exercise_price: Each OP Unit is redeemable at the election of the holder for cash equal to the then fair market value of one share of Issuer common stock, or at the Issuer's election, one share of Issuer's common stock, subject to adjustment as set forth in the partnership agreement. OP Units do not expire. F3 · derivative.exercise_date: 100% of the reporting person's PIUs granted on June 6, 2024 vested and converted into OP Units on June 6, 2025. F3 · derivative.expiration_date: 100% of the reporting person's PIUs granted on June 6, 2024 vested and converted into OP Units on June 6, 2025. Read SEC document
May 09, 2025 Filed May 13, 2025 20:19 UTC	INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707	GrantCommon Stock	19,592	$0.00	$0.00	Disclosure SEC source: 0000917520-25-000046 · wk-form4_1747167562.xml · nonDerivative · entry 2 HILL BARBARA B · CIK 0001235676 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 126,853 Read SEC document
May 09, 2025 Filed May 13, 2025 20:19 UTC	INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707	GrantCommon Stock	6,939	$0.00	$0.00	Disclosure SEC source: 0000917520-25-000046 · wk-form4_1747167562.xml · nonDerivative · entry 1 HILL BARBARA B · CIK 0001235676 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 107,261 Read SEC document
June 07, 2024 Filed Jun 11, 2024 20:07 UTC	OMEGA HEALTHCARE INVESTORS INC OHI · Entity 3362	Exercise / conversionOP Units · Derivative	8,087	$0.00	$0.00	Disclosure SEC source: 0001415889-24-016350 · form4-06112024_080611.xml · derivative · entry 3 HILL BARBARA B · CIK 0001235676 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,122 Underlying: Common Stock · 8,087 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each OP Unit is redeemable at the election of the holder for cash equal to the then fair market value of one share of Issuer common stock, or at the Issuer's election, one share of Issuer's common stock, subject to adjustment as set forth in the partnership agreement. OP Units do not expire. F2 · derivative.exercise_date: Each OP Unit is redeemable at the election of the holder for cash equal to the then fair market value of one share of Issuer common stock, or at the Issuer's election, one share of Issuer's common stock, subject to adjustment as set forth in the partnership agreement. OP Units do not expire. F2 · derivative.expiration_date: Each OP Unit is redeemable at the election of the holder for cash equal to the then fair market value of one share of Issuer common stock, or at the Issuer's election, one share of Issuer's common stock, subject to adjustment as set forth in the partnership agreement. OP Units do not expire. Read SEC document
June 07, 2024 Filed Jun 11, 2024 20:07 UTC	OMEGA HEALTHCARE INVESTORS INC OHI · Entity 3362	Exercise / conversionProfits Interest Units · Derivative	8,087	$0.00	$0.00	Disclosure SEC source: 0001415889-24-016350 · form4-06112024_080611.xml · derivative · entry 2 HILL BARBARA B · CIK 0001235676 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,872 Underlying: OP Units · 8,087 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Represents Profits Interest Units ("PIUs") in OHI Healthcare Properties Limited Partnership (the "Operating Partnership"), of which the Issuer is the general partner. Each PIU represents a contingent right to receive one unit of limited partnership interest (an "OP Unit") in the Operating Partnership upon vesting and the satisfaction of certain tax-driven economic requirements. F2 · derivative.exercise_price: Each OP Unit is redeemable at the election of the holder for cash equal to the then fair market value of one share of Issuer common stock, or at the Issuer's election, one share of Issuer's common stock, subject to adjustment as set forth in the partnership agreement. OP Units do not expire. F6 · derivative.exercise_date: 100% of the reporting person's PIUs granted on June 5, 2023 vested and converted into OP Units on June 7, 2024. F6 · derivative.expiration_date: 100% of the reporting person's PIUs granted on June 5, 2023 vested and converted into OP Units on June 7, 2024. F5 · balance_after: Includes 6,400 vested PIUs which can be converted to OP units if certain tax-related conditions are met. Read SEC document
June 07, 2024 Filed Jun 11, 2024 20:07 UTC	OMEGA HEALTHCARE INVESTORS INC OHI · Entity 3362	GrantProfits Interest Units · Derivative	7,472	$0.00	$0.00	Disclosure SEC source: 0001415889-24-016350 · form4-06112024_080611.xml · derivative · entry 1 HILL BARBARA B · CIK 0001235676 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,959 Underlying: OP Units · 7,472 shares Expires not disclosed F1 · derivative.exercise_price: Represents Profits Interest Units ("PIUs") in OHI Healthcare Properties Limited Partnership (the "Operating Partnership"), of which the Issuer is the general partner. Each PIU represents a contingent right to receive one unit of limited partnership interest (an "OP Unit") in the Operating Partnership upon vesting and the satisfaction of certain tax-driven economic requirements. F2 · derivative.exercise_price: Each OP Unit is redeemable at the election of the holder for cash equal to the then fair market value of one share of Issuer common stock, or at the Issuer's election, one share of Issuer's common stock, subject to adjustment as set forth in the partnership agreement. OP Units do not expire. F3 · shares: Represents the annual grant of stock the reporting person election to receive as Profits Interest Units. F4 · derivative.exercise_date: 100% of the reporting person's PIUs granted on June 7, 2024 will vest on the date of the Company's 2025 Annual Meeting of Shareholders, subject to continued service. F4 · derivative.expiration_date: 100% of the reporting person's PIUs granted on June 7, 2024 will vest on the date of the Company's 2025 Annual Meeting of Shareholders, subject to continued service. F5 · balance_after: Includes 6,400 vested PIUs which can be converted to OP units if certain tax-related conditions are met. Read SEC document
June 07, 2024 Filed Jun 10, 2025 20:05 UTC	OMEGA HEALTHCARE INVESTORS INC OHI · Entity 3362	GrantProfits Interest Units · Derivative	7,079	$0.00	$0.00	Disclosure SEC source: 0001415889-25-016459 · form4-06102025_040609.xml · derivative · entry 3 HILL BARBARA B · CIK 0001235676 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,079 Underlying: OP Units · 7,079 shares Expires not disclosed F1 · derivative.exercise_price: Represents Profits Interest Units ("PIUs") in OHI Healthcare Properties Limited Partnership (the "Operating Partnership"), of which the Issuer is the general partner. Each PIU represents a contingent right to receive one unit of limited partnership interest (an "OP Unit") in the Operating Partnership upon vesting and the satisfaction of certain tax-driven economic requirements. F2 · derivative.exercise_price: Each OP Unit is redeemable at the election of the holder for cash equal to the then fair market value of one share of Issuer common stock, or at the Issuer's election, one share of Issuer's common stock, subject to adjustment as set forth in the partnership agreement. OP Units do not expire. F4 · shares: Represents the annual grant of stock the reporting person election to receive as Profits Interest Units. F5 · derivative.exercise_date: 100% of the reporting person's PIUs granted on June 6, 2025 will vest on the date of the Company's 2026 Annual Meeting of Shareholders, subject to continued service. F5 · derivative.expiration_date: 100% of the reporting person's PIUs granted on June 6, 2025 will vest on the date of the Company's 2026 Annual Meeting of Shareholders, subject to continued service. Read SEC document
June 07, 2024 Filed Jun 10, 2025 20:05 UTC	OMEGA HEALTHCARE INVESTORS INC OHI · Entity 3362	Exercise / conversionOP Units · Derivative	7,472	$0.00	$0.00	Disclosure SEC source: 0001415889-25-016459 · form4-06102025_040609.xml · derivative · entry 2 HILL BARBARA B · CIK 0001235676 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,994 Underlying: Common Stock · 7,472 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each OP Unit is redeemable at the election of the holder for cash equal to the then fair market value of one share of Issuer common stock, or at the Issuer's election, one share of Issuer's common stock, subject to adjustment as set forth in the partnership agreement. OP Units do not expire. F2 · derivative.exercise_date: Each OP Unit is redeemable at the election of the holder for cash equal to the then fair market value of one share of Issuer common stock, or at the Issuer's election, one share of Issuer's common stock, subject to adjustment as set forth in the partnership agreement. OP Units do not expire. F2 · derivative.expiration_date: Each OP Unit is redeemable at the election of the holder for cash equal to the then fair market value of one share of Issuer common stock, or at the Issuer's election, one share of Issuer's common stock, subject to adjustment as set forth in the partnership agreement. OP Units do not expire. Read SEC document
May 21, 2024 Filed May 22, 2024 20:09 UTC	INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707	PurchaseCommon Stock	36,350	$27.40	$995,815.52	Disclosure SEC source: 0000917520-24-000075 · wk-form4_1716408548.xml · nonDerivative · entry 2 HILL BARBARA B · CIK 0001235676 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 36,350 F1 · price: The price shown above represents the weighted average price of the shares purchased. The range of the purchase prices was $27.15 to $27.47 The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document
May 09, 2024 Filed May 13, 2024 20:55 UTC	INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707	GrantCommon Stock	8,696	$0.00	$0.00	Disclosure SEC source: 0000917520-24-000068 · wk-form4_1715633732.xml · nonDerivative · entry 2 HILL BARBARA B · CIK 0001235676 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,322 Read SEC document
May 09, 2024 Filed May 13, 2024 20:55 UTC	INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707	GrantCommon Stock	3,163	$0.00	$0.00	Disclosure SEC source: 0000917520-24-000068 · wk-form4_1715633732.xml · nonDerivative · entry 1 HILL BARBARA B · CIK 0001235676 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 91,626 Read SEC document
June 05, 2023 Filed Jun 7, 2023 21:33 UTC	OMEGA HEALTHCARE INVESTORS INC OHI · Entity 3362	Exercise / conversionOP Units · Derivative	8,304	$0.00	$0.00	Disclosure SEC source: 0001415889-23-009386 · form4-06072023_090621.xml · derivative · entry 3 HILL BARBARA B · CIK 0001235676 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,035 Underlying: Common Stock · 8,304 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each OP Unit is redeemable at the election of the holder for cash equal to the then fair market value of one share of Issuer common stock, or at the Issuer's election, one share of Issuer's common stock, subject to adjustment as set forth in the partnership agreement. OP Units do not expire. F2 · derivative.exercise_date: Each OP Unit is redeemable at the election of the holder for cash equal to the then fair market value of one share of Issuer common stock, or at the Issuer's election, one share of Issuer's common stock, subject to adjustment as set forth in the partnership agreement. OP Units do not expire. F2 · derivative.expiration_date: Each OP Unit is redeemable at the election of the holder for cash equal to the then fair market value of one share of Issuer common stock, or at the Issuer's election, one share of Issuer's common stock, subject to adjustment as set forth in the partnership agreement. OP Units do not expire. F4 · balance_after: Includes 6,400 vested PIUs which can be converted to OP units if certain tax-related conditions are met. Read SEC document
June 05, 2023 Filed Jun 7, 2023 21:33 UTC	OMEGA HEALTHCARE INVESTORS INC OHI · Entity 3362	Exercise / conversionProfits Interest Units · Derivative	8,304	$0.00	$0.00	Disclosure SEC source: 0001415889-23-009386 · form4-06072023_090621.xml · derivative · entry 2 HILL BARBARA B · CIK 0001235676 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,487 Underlying: OP Units · 8,304 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Represents Profits Interest Units ("PIUs") in OHI Healthcare Properties Limited Partnership (the "Operating Partnership"), of which the Issuer is the general partner. Each PIU represents a contingent right to receive one unit of limited partnership interest (an "OP Unit") in the Operating Partnership upon vesting and the satisfaction of certain tax-driven economic requirements. F2 · derivative.exercise_price: Each OP Unit is redeemable at the election of the holder for cash equal to the then fair market value of one share of Issuer common stock, or at the Issuer's election, one share of Issuer's common stock, subject to adjustment as set forth in the partnership agreement. OP Units do not expire. F5 · derivative.exercise_date: 100% of the reporting person's PIUs granted on June 3, 2022 vested and converted into OP Units on June 5, 2023. F5 · derivative.expiration_date: 100% of the reporting person's PIUs granted on June 3, 2022 vested and converted into OP Units on June 5, 2023. F4 · balance_after: Includes 6,400 vested PIUs which can be converted to OP units if certain tax-related conditions are met. Read SEC document
June 05, 2023 Filed Jun 7, 2023 21:33 UTC	OMEGA HEALTHCARE INVESTORS INC OHI · Entity 3362	GrantProfits Interest Units · Derivative	8,087	$0.00	$0.00	Disclosure SEC source: 0001415889-23-009386 · form4-06072023_090621.xml · derivative · entry 1 HILL BARBARA B · CIK 0001235676 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,791 Underlying: OP Units · 8,087 shares Expires not disclosed F1 · derivative.exercise_price: Represents Profits Interest Units ("PIUs") in OHI Healthcare Properties Limited Partnership (the "Operating Partnership"), of which the Issuer is the general partner. Each PIU represents a contingent right to receive one unit of limited partnership interest (an "OP Unit") in the Operating Partnership upon vesting and the satisfaction of certain tax-driven economic requirements. F2 · derivative.exercise_price: Each OP Unit is redeemable at the election of the holder for cash equal to the then fair market value of one share of Issuer common stock, or at the Issuer's election, one share of Issuer's common stock, subject to adjustment as set forth in the partnership agreement. OP Units do not expire. F3 · derivative.exercise_date: 100% of the reporting person's PIUs granted on June 5, 2023 will vest on the date of the Company's 2024 Annual Meeting of Shareholders, subject to continued service. F3 · derivative.expiration_date: 100% of the reporting person's PIUs granted on June 5, 2023 will vest on the date of the Company's 2024 Annual Meeting of Shareholders, subject to continued service. F4 · balance_after: Includes 6,400 vested PIUs which can be converted to OP units if certain tax-related conditions are met. Read SEC document
May 12, 2023 Filed May 16, 2023 20:26 UTC	INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707	GrantCommon Stock	4,486	$0.00	$0.00	Disclosure SEC source: 0001209191-23-029801 · doc4.xml · nonDerivative · entry 2 HILL BARBARA B · CIK 0001235676 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 88,463 Read SEC document
May 12, 2023 Filed May 16, 2023 20:26 UTC	INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707	GrantCommon Stock	1,631	$0.00	$0.00	Disclosure SEC source: 0001209191-23-029801 · doc4.xml · nonDerivative · entry 1 HILL BARBARA B · CIK 0001235676 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 83,977 Read SEC document
June 03, 2022 Filed Jun 7, 2022 00:41 UTC	OMEGA HEALTHCARE INVESTORS INC OHI · Entity 3362	GrantProfits Interest Units · Derivative	8,304	$0.00	$0.00	Disclosure SEC source: 0001415889-22-006184 · form4-06062022_050628.xml · derivative · entry 1 HILL BARBARA B · CIK 0001235676 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,704 Underlying: OP Units · 8,304 shares Expires not disclosed F1 · derivative.exercise_price: Represents Profits Interest Units ("Profits Units") in OHI Healthcare Properties Limited Partnership (the "Operating Partnership"), of which the Issuer is the general partner. Each Profits Unit can be converted into one unit of limited partnership interest (an "OP Unit") in the Operating Partnership following vesting and the satisfaction of certain tax-driven economic requirements. F2 · derivative.exercise_price: Each OP Unit is redeemable at the election of the holder for cash equal to the then fair market value of one share of Issuer common stock, or at the Issuer's election, one share of Issuer's common stock, subject to adjustment as set forth in the partnership agreement. OP Units do not expire. F3 · shares: Represents the annual grant of stock the reporting person elected to receive as Profits Interest Units. F4 · derivative.exercise_date: 100% of the reporting person's Profits Interest Units granted on June 3, 2022 will vest on the date of the Company's 2023 Annual Meeting of Shareholders, subject to continued service. F4 · derivative.expiration_date: 100% of the reporting person's Profits Interest Units granted on June 3, 2022 will vest on the date of the Company's 2023 Annual Meeting of Shareholders, subject to continued service. F5 · balance_after: Includes 6,400 vested Profits Interest Units which can be converted to OP units if certain tax-related conditions are met. Read SEC document
May 13, 2022 Filed May 17, 2022 20:48 UTC	INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707	GrantCommon Stock	3,456	$0.00	$0.00	Disclosure SEC source: 0001209191-22-029716 · doc4.xml · nonDerivative · entry 2 HILL BARBARA B · CIK 0001235676 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,346 Read SEC document
May 13, 2022 Filed May 17, 2022 20:48 UTC	INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707	GrantCommon Stock	1,265	$0.00	$0.00	Disclosure SEC source: 0001209191-22-029716 · doc4.xml · nonDerivative · entry 1 HILL BARBARA B · CIK 0001235676 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,890 Read SEC document
July 22, 2021 Filed Jul 26, 2021 20:07 UTC	OMEGA HEALTHCARE INVESTORS INC OHI · Entity 3362	GrantProfit Interest Units · Derivative	791	$0.00	$0.00	Disclosure SEC source: 0001127602-21-022497 · form4.xml · derivative · entry 3 HILL BARBARA B · CIK 0001235676 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,400 Underlying: OP Units · 791 shares Expires not disclosed F1 · derivative.exercise_price: Represents Profits Interest Units ("Profits Units") in OHI Healthcare Properties Limited Partnership (the "Operating Partnership"), of which the Issuer is the general partner. Each Profits Unit can be converted into one unit of limited partnership interest (an "OP Unit") in the Operating Partnership following vesting and the satisfaction of certain tax-driven economic requirements. F2 · derivative.exercise_price: Each OP Unit is redeemable at the election of the holder for cash equal to the then fair market value of one share of Issuer common stock, or at the Issuer's election, one share of Issuer common stock, subject to adjustment as set forth in the partnership agreement. OP Units do not expire. F4 · shares: Incremental Profits Interest Units granted for 2021 reflecting a revision to Omega's annual Director compensation program. F3 · derivative.exercise_date: 100% of the reporting persons Profits Interest Units granted on 6/7/2021 will vest on the date of the Company's 2022 Annual Meeting of shareholders, subject to continued Board service. F3 · derivative.expiration_date: 100% of the reporting persons Profits Interest Units granted on 6/7/2021 will vest on the date of the Company's 2022 Annual Meeting of shareholders, subject to continued Board service. Read SEC document
June 07, 2021 Filed Jun 9, 2021 19:02 UTC	OMEGA HEALTHCARE INVESTORS INC OHI · Entity 3362	GrantProfit Interest Units · Derivative	5,609	$0.00	$0.00	Disclosure SEC source: 0001127602-21-019494 · form4.xml · derivative · entry 1 HILL BARBARA B · CIK 0001235676 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,782 Underlying: OP Units · 5,609 shares Expires not disclosed F1 · derivative.exercise_price: Represents Profits Interest Units ("Profits Units") in OHI Healthcare Properties Limited Partnership (the "Operating Partnership"), of which the Issuer is the general partner. Each Profits Unit can be converted into one unit of limited partnership interest (an "OP Unit") in the Operating Partnership following vesting and the satisfaction of certain tax-driven economic requirements. F2 · derivative.exercise_price: Each OP Unit is redeemable at the election of the holder for cash equal to the then fair market value of one share of Issuer common stock, or at the Issuer's election, one share of Issuer common stock, subject to adjustment as set forth in the partnership agreement. OP Units do not expire. F3 · shares: Represents the annual grant of stock the reporting person elected to receive as Profits Interest Units. F4 · derivative.exercise_date: 100% of the reporting persons Profits Interest Units granted on 6/7/2021 will vest on the date of the Company's 2022 Annual Meeting of shareholders, subject to continued Board service. F4 · derivative.expiration_date: 100% of the reporting persons Profits Interest Units granted on 6/7/2021 will vest on the date of the Company's 2022 Annual Meeting of shareholders, subject to continued Board service. Read SEC document
June 03, 2021 Filed Jul 26, 2021 20:07 UTC	OMEGA HEALTHCARE INVESTORS INC OHI · Entity 3362	Exercise / conversionOP Units · Derivative	6,173	$0.00	$0.00	Disclosure SEC source: 0001127602-21-022497 · form4.xml · derivative · entry 2 HILL BARBARA B · CIK 0001235676 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,731 Underlying: Common Stock · 6,173 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each OP Unit is redeemable at the election of the holder for cash equal to the then fair market value of one share of Issuer common stock, or at the Issuer's election, one share of Issuer common stock, subject to adjustment as set forth in the partnership agreement. OP Units do not expire. F2 · derivative.exercise_date: Each OP Unit is redeemable at the election of the holder for cash equal to the then fair market value of one share of Issuer common stock, or at the Issuer's election, one share of Issuer common stock, subject to adjustment as set forth in the partnership agreement. OP Units do not expire. F2 · derivative.expiration_date: Each OP Unit is redeemable at the election of the holder for cash equal to the then fair market value of one share of Issuer common stock, or at the Issuer's election, one share of Issuer common stock, subject to adjustment as set forth in the partnership agreement. OP Units do not expire. Read SEC document
June 03, 2021 Filed Jul 26, 2021 20:07 UTC	OMEGA HEALTHCARE INVESTORS INC OHI · Entity 3362	Exercise / conversionProfit Interest Units · Derivative	6,173	$0.00	$0.00	Disclosure SEC source: 0001127602-21-022497 · form4.xml · derivative · entry 1 HILL BARBARA B · CIK 0001235676 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,609 Underlying: OP Units · 6,173 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Represents Profits Interest Units ("Profits Units") in OHI Healthcare Properties Limited Partnership (the "Operating Partnership"), of which the Issuer is the general partner. Each Profits Unit can be converted into one unit of limited partnership interest (an "OP Unit") in the Operating Partnership following vesting and the satisfaction of certain tax-driven economic requirements. F2 · derivative.exercise_price: Each OP Unit is redeemable at the election of the holder for cash equal to the then fair market value of one share of Issuer common stock, or at the Issuer's election, one share of Issuer common stock, subject to adjustment as set forth in the partnership agreement. OP Units do not expire. F3 · derivative.exercise_date: 100% of the reporting persons Profits Interest Units granted on 6/7/2021 will vest on the date of the Company's 2022 Annual Meeting of shareholders, subject to continued Board service. F3 · derivative.expiration_date: 100% of the reporting persons Profits Interest Units granted on 6/7/2021 will vest on the date of the Company's 2022 Annual Meeting of shareholders, subject to continued Board service. Read SEC document
May 14, 2021 Filed May 17, 2021 20:14 UTC	INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707	GrantCommon Stock	2,896	$0.00	$0.00	Disclosure SEC source: 0001209191-21-033131 · doc4.xml · nonDerivative · entry 2 HILL BARBARA B · CIK 0001235676 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,625 Read SEC document
May 14, 2021 Filed May 17, 2021 20:14 UTC	INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707	GrantCommon Stock	1,060	$0.00	$0.00	Disclosure SEC source: 0001209191-21-033131 · doc4.xml · nonDerivative · entry 1 HILL BARBARA B · CIK 0001235676 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,729 Read SEC document
June 11, 2020 Filed Jun 15, 2020 19:36 UTC	OMEGA HEALTHCARE INVESTORS INC OHI · Entity 3362	GrantProfit Interest Units · Derivative	6,173	$0.00	$0.00	Disclosure SEC source: 0001127602-20-019566 · form4.xml · derivative · entry 3 HILL BARBARA B · CIK 0001235676 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,173 Underlying: OP Units · 6,173 shares Expires not disclosed F1 · derivative.exercise_price: Represents Profits Interest Units ("Profits Units") in OHI Healthcare Properties Limited Partnership (the "Operating Partnership"), of which the Issuer is the general partner. Each Profits Unit can be converted into one unit of limited partnership interest (an "OP Unit") in the Operating Partnership following vesting and the satisfaction of certain tax-driven economic requirements. Profits Units were granted the reporting person on 6/7/2019. F2 · derivative.exercise_price: Each OP Unit is redeemable at the election of the holder for cash equal to the then fair market value of one share of Issuer common stock, or at the Issuer's election, one share of Issuer common stock, subject to adjustment as set forth in the partnership agreement. OP Units do not expire. F5 · derivative.exercise_date: 100% of the reporting persons Profits Interest Units granted on 6/11/2020 will vest on the date of the Company's 2021 Annual Meeting of shareholders, subject to continued Board service. F5 · derivative.expiration_date: 100% of the reporting persons Profits Interest Units granted on 6/11/2020 will vest on the date of the Company's 2021 Annual Meeting of shareholders, subject to continued Board service. Read SEC document
June 11, 2020 Filed Jun 15, 2020 19:36 UTC	OMEGA HEALTHCARE INVESTORS INC OHI · Entity 3362	Exercise / conversionOP Units · Derivative	5,558	$0.00	$0.00	Disclosure SEC source: 0001127602-20-019566 · form4.xml · derivative · entry 2 HILL BARBARA B · CIK 0001235676 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,558 Underlying: Common Stock · 5,558 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each OP Unit is redeemable at the election of the holder for cash equal to the then fair market value of one share of Issuer common stock, or at the Issuer's election, one share of Issuer common stock, subject to adjustment as set forth in the partnership agreement. OP Units do not expire. F4 · derivative.exercise_date: Each OP Unit is redeemable at the election of the holder for cash equal to the then fair market value of one share of Issuer common stock, or at the Issuer's election, one share of Issuer common stock, subject to adjustment as set forth in the partnership agreement. OP Units do not expire. F4 · derivative.expiration_date: Each OP Unit is redeemable at the election of the holder for cash equal to the then fair market value of one share of Issuer common stock, or at the Issuer's election, one share of Issuer common stock, subject to adjustment as set forth in the partnership agreement. OP Units do not expire. Read SEC document
June 11, 2020 Filed Jun 15, 2020 19:36 UTC	OMEGA HEALTHCARE INVESTORS INC OHI · Entity 3362	Exercise / conversionProfit Interest Units · Derivative	5,558	$0.00	$0.00	Disclosure SEC source: 0001127602-20-019566 · form4.xml · derivative · entry 1 HILL BARBARA B · CIK 0001235676 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: OP Units · 5,558 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Represents Profits Interest Units ("Profits Units") in OHI Healthcare Properties Limited Partnership (the "Operating Partnership"), of which the Issuer is the general partner. Each Profits Unit can be converted into one unit of limited partnership interest (an "OP Unit") in the Operating Partnership following vesting and the satisfaction of certain tax-driven economic requirements. Profits Units were granted the reporting person on 6/7/2019. F2 · derivative.exercise_price: Each OP Unit is redeemable at the election of the holder for cash equal to the then fair market value of one share of Issuer common stock, or at the Issuer's election, one share of Issuer common stock, subject to adjustment as set forth in the partnership agreement. OP Units do not expire. F3 · derivative.exercise_date: 100% of the reporting persons Profits Interest Units granted on 6/7/2019 vested and converted in OP Units on 6/11/2020. F3 · derivative.expiration_date: 100% of the reporting persons Profits Interest Units granted on 6/7/2019 vested and converted in OP Units on 6/11/2020. Read SEC document
May 13, 2020 Filed May 15, 2020 20:09 UTC	INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707	GrantCommon Stock	4,218	$0.00	$0.00	Disclosure SEC source: 0001209191-20-029714 · doc4.xml · nonDerivative · entry 2 HILL BARBARA B · CIK 0001235676 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,669 Read SEC document
May 13, 2020 Filed May 15, 2020 20:09 UTC	INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707	GrantCommon Stock	791	$0.00	$0.00	Disclosure SEC source: 0001209191-20-029714 · doc4.xml · nonDerivative · entry 1 HILL BARBARA B · CIK 0001235676 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,451 Read SEC document
June 28, 2019 Filed Jul 2, 2019 20:13 UTC	ACCENDRA HEALTH INC/VA/ OMI · Entity 6858	GrantPhantom Stock · Derivative	17	$3.20	$54.40	Disclosure SEC source: 0000075252-19-000101 · edgar.xml · derivative · entry 1 HILL BARBARA B · CIK 0001235676 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,718 Underlying: Common Stock · 17 shares Expires not disclosed F1 · derivative.exercise_price: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). F2 · shares: Shares acquired through quarterly dividend reinvestment transaction. F1 · derivative.exercise_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). F1 · derivative.expiration_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). Read SEC document
June 07, 2019 Filed Jun 11, 2019 19:08 UTC	OMEGA HEALTHCARE INVESTORS INC OHI · Entity 3362	GrantProfit Interest Units · Derivative	5,558	$35.98	$199,976.84	Disclosure SEC source: 0001127602-19-021320 · form4.xml · derivative · entry 1 HILL BARBARA B · CIK 0001235676 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,558 Underlying: OP Units · 5,558 shares Expires not disclosed F1 · derivative.exercise_price: Represents Profits Interest Units ("Profits Units") in OHI Healthcare Properties Limited Partnership (the "Operating Partnership"), of which the Issuer is the general partner. Each Profits Unit represents a contingent right to receive one unit of limited partnership interest (an "OP Unit") in the Operating Partnership upon vesting and the satisfaction of certain tax-driven economic requirements. Each OP Unit is redeemable at the election of the holder for cash equal to the then fair market value of one share of Issuer common stock, or at the Issuer's election, one share of Issuer common stock, subject to adjustment as set forth in the partnership agreement. F2 · shares: Represents annual grant of Restricted Stock the reporting person elected to take as Profits Interest Units. F3 · derivative.exercise_date: Profits Interest Units vesting on the date of the 2020 annual meeting, subject to continued service and acceleration upon certain events. F3 · derivative.expiration_date: Profits Interest Units vesting on the date of the 2020 annual meeting, subject to continued service and acceleration upon certain events. Read SEC document
June 03, 2019 Filed Jun 4, 2019 21:03 UTC	ACCENDRA HEALTH INC/VA/ OMI · Entity 6858	GrantPhantom Stock · Derivative	13,230	$2.74	$36,250.20	Disclosure SEC source: 0000075252-19-000096 · edgar.xml · derivative · entry 1 HILL BARBARA B · CIK 0001235676 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,701 Underlying: Common Stock · 13,230 shares Expires not disclosed F1 · derivative.exercise_price: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). F1 · derivative.exercise_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). F1 · derivative.expiration_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). Read SEC document
May 16, 2019 Filed May 20, 2019 20:25 UTC	INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707	GrantCommon Stock	1,494	$0.00	$0.00	Disclosure SEC source: 0001209191-19-031386 · doc4.xml · nonDerivative · entry 2 HILL BARBARA B · CIK 0001235676 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,660 Read SEC document
May 16, 2019 Filed May 20, 2019 20:25 UTC	INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707	GrantCommon Stock	3,785	$0.00	$0.00	Disclosure SEC source: 0001209191-19-031386 · doc4.xml · nonDerivative · entry 1 HILL BARBARA B · CIK 0001235676 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,166 Read SEC document
May 13, 2019 Filed May 15, 2019 20:47 UTC	ACCENDRA HEALTH INC/VA/ OMI · Entity 6858	GrantCommon Stock	32,637	$0.00	$0.00	Disclosure SEC source: 0000075252-19-000080 · edgar.xml · nonDerivative · entry 1 HILL BARBARA B · CIK 0001235676 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,738 F1 · security: Restricted stock with a one year vesting date. Read SEC document
March 29, 2019 Filed Apr 2, 2019 21:02 UTC	ACCENDRA HEALTH INC/VA/ OMI · Entity 6858	GrantPhantom Stock · Derivative	5	$4.10	$20.50	Disclosure SEC source: 0000075252-19-000061 · edgar.xml · derivative · entry 1 HILL BARBARA B · CIK 0001235676 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,471 Underlying: Common Stock · 5 shares Expires not disclosed F1 · derivative.exercise_price: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). F2 · shares: Shares acquired through quarterly dividend reinvestment transaction. F1 · derivative.exercise_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). F1 · derivative.expiration_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). Read SEC document
January 02, 2019 Filed Jan 4, 2019 19:57 UTC	ACCENDRA HEALTH INC/VA/ OMI · Entity 6858	GrantPhantom Stock · Derivative	96	$6.51	$624.96	Disclosure SEC source: 0000075252-19-000006 · edgar.xml · derivative · entry 1 HILL BARBARA B · CIK 0001235676 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,466 Underlying: Common Stock · 96 shares Expires not disclosed F1 · derivative.exercise_price: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). F2 · shares: Shares acquired through quarterly dividend reinvestment transaction. F1 · derivative.exercise_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). F1 · derivative.expiration_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). Read SEC document
November 07, 2018 Filed Nov 13, 2018 21:18 UTC	ACCENDRA HEALTH INC/VA/ OMI · Entity 6858	GrantPhantom Stock · Derivative	1,099	$9.10	$10,000.90	Disclosure SEC source: 0000075252-18-000139 · edgar.xml · derivative · entry 1 HILL BARBARA B · CIK 0001235676 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,370 Underlying: Common Stock · 1,099 shares Expires not disclosed F1 · derivative.exercise_price: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). F1 · derivative.exercise_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). F1 · derivative.expiration_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). Read SEC document
November 05, 2018 Filed Nov 6, 2018 22:01 UTC	INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707	PurchaseCommon Stock	3,705	$53.90	$199,683.20	Disclosure SEC source: 0001209191-18-057431 · doc4.xml · nonDerivative · entry 1 HILL BARBARA B · CIK 0001235676 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,381 F1 · price: The price shown above represents the weighted average price of the shares sold. The range of sale prices was $53.7131 to $53.99. Read SEC document
October 01, 2018 Filed Oct 2, 2018 21:26 UTC	ACCENDRA HEALTH INC/VA/ OMI · Entity 6858	GrantPhantom Stock · Derivative	114	$16.26	$1,853.64	Disclosure SEC source: 0000075252-18-000128 · edgar.xml · derivative · entry 1 HILL BARBARA B · CIK 0001235676 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,271 Underlying: Common Stock · 114 shares Expires not disclosed F1 · derivative.exercise_price: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). F2 · shares: Shares acquired through quarterly dividend reinvestment transaction. F1 · derivative.exercise_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). F1 · derivative.expiration_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). Read SEC document
July 02, 2018 Filed Jul 3, 2018 18:26 UTC	ACCENDRA HEALTH INC/VA/ OMI · Entity 6858	GrantPhantom Stock · Derivative	110	$16.63	$1,829.30	Disclosure SEC source: 0000075252-18-000107 · edgar.xml · derivative · entry 1 HILL BARBARA B · CIK 0001235676 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,157 Underlying: Common Stock · 110 shares Expires not disclosed F1 · derivative.exercise_price: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). F2 · shares: Shares acquired through quarterly dividend reinvestment transaction. F1 · derivative.exercise_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). F1 · derivative.expiration_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d). Read SEC document
June 08, 2018 Filed Jun 12, 2018 14:18 UTC	OMEGA HEALTHCARE INVESTORS INC OHI · Entity 3362	GrantCommon Stock	6,588	$30.36	$200,011.68	Disclosure SEC source: 0001127602-18-020656 · form4.xml · nonDerivative · entry 1 HILL BARBARA B · CIK 0001235676 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,310 F1 · shares: Represents annual grant of restricted stock subject to time-based vesting. Read SEC document
May 17, 2018 Filed May 18, 2018 20:12 UTC	ACCENDRA HEALTH INC/VA/ OMI · Entity 6858	GrantCommon Stock	10,355	$0.00	$0.00	Disclosure SEC source: 0000075252-18-000086 · edgar.xml · nonDerivative · entry 1 HILL BARBARA B · CIK 0001235676 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,101 F1 · security: Restricted stock with a one year vesting date. Read SEC document
May 17, 2018 Filed May 21, 2018 20:48 UTC	INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707	GrantCommon Stock	2,965	$0.00	$0.00	Disclosure SEC source: 0001209191-18-031909 · doc4.xml · nonDerivative · entry 2 HILL BARBARA B · CIK 0001235676 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,676 Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.